However, these differences did not reach statistical significance.
← all excerpts
The GPVI-Fc fusion protein Revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times.
1
—
—
However, these differences did not reach statistical significance.